StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$6.24−0.07 (-1.11%)

Close on Nov 12, 2026Market cap $42.32MP/E –Yield –

Instil Bio total assets

Total assets on the balance sheet at the end of each period.

Instil Bio's total assets was $197.71M at Jun 30, 2026. For fiscal 2025 it was $203.52M, down 22.8% from the year before. The highest annual figure on record is $609.98M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$203.52M-22.8%
FY2024Dec 31, 2024$263.57M-19.1%
FY2023Dec 31, 2023$325.63M-32.5%
FY2022Dec 31, 2022$482.13M-21.0%
FY2021Dec 31, 2021$609.98M+91.2%
FY2020Dec 31, 2020$319.01M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$197.71M-14.4%
Q1 FY2026Mar 31, 2026$200.43M-15.6%
Q4 FY2025Dec 31, 2025$203.52M-22.8%
Q3 FY2025Sep 30, 2025$211.77M-22.3%
Q2 FY2025Jun 30, 2025$230.99M-21.5%
Q1 FY2025Mar 31, 2025$237.45M-22.5%
Q4 FY2024Dec 31, 2024$263.57M-19.1%
Q3 FY2024Sep 30, 2024$272.56M-19.9%
Q2 FY2024Jun 30, 2024$294.32M-27.9%
Q1 FY2024Mar 31, 2024$306.30M-28.3%
Q4 FY2023Dec 31, 2023$325.63M-32.5%
Q3 FY2023Sep 30, 2023$340.27M-36.1%
Q2 FY2023Jun 30, 2023$408.31M-28.2%
Q1 FY2023Mar 31, 2023$427.17M-24.4%
Q4 FY2022Dec 31, 2022$482.13M-21.0%
Q3 FY2022Sep 30, 2022$532.74M-17.7%
Q2 FY2022Jun 30, 2022$568.54M-15.5%
Q1 FY2022Mar 31, 2022$564.94M-18.8%
Q4 FY2021Dec 31, 2021$609.98M+91.2%
Q3 FY2021Sep 30, 2021$647.40M–
Q2 FY2021Jun 30, 2021$672.67M–
Q1 FY2021Mar 31, 2021$696.14M–
Q4 FY2020Dec 31, 2020$319.01M–

More Instil Bio figures

See a number that looks wrong?